These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2144854)

  • 1. Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography.
    Novick D; Engelmann H; Wallach D; Leitner O; Revel M; Rubinstein M
    J Chromatogr; 1990 Jun; 510():331-7. PubMed ID: 2144854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble cytokine receptors are present in normal human urine.
    Novick D; Engelmann H; Wallach D; Rubinstein M
    J Exp Med; 1989 Oct; 170(4):1409-14. PubMed ID: 2529343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding.
    Novick D; Engelmann H; Revel M; Leitner O; Rubinstein M
    Hybridoma; 1991 Feb; 10(1):137-46. PubMed ID: 2032732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to the human interferon-gamma receptor: blocking of the biological activities of interferon-gamma and purification of the receptor.
    Novick D; Fischer DG; Reiter Z; Eshhar Z; Rubinstein M
    J Interferon Res; 1989 Jun; 9(3):315-28. PubMed ID: 2526186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to human immune interferon and their application for affinity chromatography.
    Le J; Barrowclough BS; Vilcek J
    J Immunol Methods; 1984 Apr; 69(1):61-70. PubMed ID: 6425412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies for affinity purification of IL-6/IFN- beta 2 and for neutralization of HGF activity.
    Novick D; Eshhar Z; Revel M; Mory Y
    Hybridoma; 1989 Oct; 8(5):561-7. PubMed ID: 2680901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and biochemical characterization of a soluble human interferon gamma receptor expressed in Escherichia coli.
    Fountoulakis M; Juranville JF; Stüber D; Weibel EK; Garotta G
    J Biol Chem; 1990 Aug; 265(22):13268-75. PubMed ID: 2142945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and biochemical characterization of a soluble mouse interferon-gamma receptor produced in insect cells.
    Fountoulakis M; Schlaeger EJ; Gentz R; Juranville JF; Manneberg M; Ozmen L; Garotta G
    Eur J Biochem; 1991 Jun; 198(2):441-50. PubMed ID: 1828230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human interferon-gamma receptor. Purification, characterization, and preparation of antibodies.
    Novick D; Orchansky P; Revel M; Rubinstein M
    J Biol Chem; 1987 Jun; 262(18):8483-7. PubMed ID: 2954953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human interferon-gamma receptor. Mapping of epitopes recognized by neutralizing antibodies using native and recombinant receptor proteins.
    Garotta G; Ozmen L; Fountoulakis M; Dembic Z; van Loon AP; Stüber D
    J Biol Chem; 1990 Apr; 265(12):6908-15. PubMed ID: 1691178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
    Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
    J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel solid-phase test to study the binding of IFN-gamma to its receptor.
    Ozmen L; Fountoulakis M; Garotta G
    J Immunol Methods; 1992 Mar; 147(2):261-70. PubMed ID: 1372336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification.
    Stoyan T; Michaelis U; Schooltink H; Van Dam M; Rudolph R; Heinrich PC; Rose-John S
    Eur J Biochem; 1993 Aug; 216(1):239-45. PubMed ID: 8365410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to human interferon-gamma: production, affinity purification and radioimmunoassay.
    Novick D; Eshhar Z; Fischer DG; Friedlander J; Rubinstein M
    EMBO J; 1983; 2(9):1527-30. PubMed ID: 11892806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of natural human IFN-gamma antibodies.
    Viani E; Flamminio G; Caruso A; Foresti I; De Francesco M; Pollara P; Balsari A; Turano A
    Immunol Lett; 1991 Sep; 30(1):53-8. PubMed ID: 1959942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.
    Matsuda T; Hirano T; Kishimoto T
    Eur J Immunol; 1988 Jun; 18(6):951-6. PubMed ID: 3260187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma.
    Sanceau J; Wijdenes J; Revel M; Wietzerbin J
    J Immunol; 1991 Oct; 147(8):2630-7. PubMed ID: 1918983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5.
    Devos R; Guisez Y; Cornelis S; Verhee A; Van der Heyden J; Manneberg M; Lahm HW; Fiers W; Tavernier J; Plaetinck G
    J Biol Chem; 1993 Mar; 268(9):6581-7. PubMed ID: 8454628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A; Barak V; Novick D; Nagler A
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.